tiprankstipranks
Trending News
More News >
ADMA Biologics (ADMA)
NASDAQ:ADMA
US Market

ADMA Biologics (ADMA) Income Statement

Compare
2,976 Followers

ADMA Biologics Income Statement

Last quarter (Q3 2025), ADMA Biologics's total revenue was $134.22M, an increase of 12.00% from the same quarter last year. In Q3, ADMA Biologics's net income was $36.43M. See ADMA Biologics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 426.45M$ 258.21M$ 154.08M$ 80.94M$ 42.22M
Gross Profit
$ 219.55M$ 88.94M$ 35.27M$ 1.17M$ -19.07M
Operating Expenses
$ 80.57M$ 67.31M$ 74.63M$ 59.55M$ 45.84M
Depreciation and Amortization
$ 8.04M$ 8.33M$ 7.11M$ 5.50M$ 3.94M
EBITDA
$ 147.69M$ 5.12M$ -39.51M$ -53.09M$ -59.82M
Operating Income
$ 138.98M$ 21.63M$ -39.37M$ -58.37M$ -64.91M
Other Income/Expenses
$ -13.27M$ -49.87M$ -26.54M$ -13.27M$ -10.83M
Pretax Income
$ 125.71M$ -28.24M$ -65.90M$ -71.65M$ -75.75M
Net Income
$ 197.67M$ -28.24M$ -65.90M$ -71.65M$ -75.75M
Per Share Metrics
Basic EPS
$ 0.85$ -0.13$ -0.43$ -0.61$ -1.02
Diluted EPS
$ 0.81$ -0.13$ -0.43$ -0.61$ -1.02
Weighted Average Shares Outstanding
233.08M 223.98M 197.87M 139.58M 86.15M
Weighted Average Shares Outstanding (Diluted)
243.34M 223.98M 197.87M 139.58M 86.15M
Currency in USD

ADMA Biologics Earnings and Revenue History